Sapient Capital LLC Reduces Stock Position in BWX Technologies, Inc. $BWXT

Sapient Capital LLC lessened its position in shares of BWX Technologies, Inc. (NYSE:BWXT) by 2.5% during the 4th quarter, Holdings Channel reports. The firm owned 282,311 shares of the technology company’s stock after selling 7,187 shares during the quarter. BWX Technologies comprises 0.7% of Sapient Capital LLC’s portfolio, making the stock its 24th largest holding. Sapient Capital LLC’s holdings in BWX Technologies were worth $49,194,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Aventura Private Wealth LLC purchased a new stake in BWX Technologies during the 4th quarter valued at about $29,000. WFA of San Diego LLC purchased a new stake in BWX Technologies during the 2nd quarter valued at about $29,000. Strategic Advocates LLC purchased a new stake in BWX Technologies during the 3rd quarter valued at about $32,000. Strategic Investment Solutions Inc. IL grew its stake in BWX Technologies by 300.0% during the 3rd quarter. Strategic Investment Solutions Inc. IL now owns 200 shares of the technology company’s stock valued at $37,000 after purchasing an additional 150 shares during the last quarter. Finally, ORG Partners LLC grew its stake in BWX Technologies by 143.2% during the 4th quarter. ORG Partners LLC now owns 231 shares of the technology company’s stock valued at $40,000 after purchasing an additional 136 shares during the last quarter. Hedge funds and other institutional investors own 94.39% of the company’s stock.

BWX Technologies Stock Down 0.1%

Shares of BWXT opened at $204.48 on Monday. BWX Technologies, Inc. has a 52 week low of $106.22 and a 52 week high of $241.82. The company has a quick ratio of 2.33, a current ratio of 2.40 and a debt-to-equity ratio of 1.58. The company has a market capitalization of $18.73 billion, a price-to-earnings ratio of 54.68, a PEG ratio of 3.37 and a beta of 0.78. The stock’s 50-day moving average price is $212.76 and its 200-day moving average price is $199.90.

BWX Technologies (NYSE:BWXT) last issued its earnings results on Monday, May 4th. The technology company reported $1.12 EPS for the quarter, topping analysts’ consensus estimates of $0.92 by $0.20. BWX Technologies had a return on equity of 31.33% and a net margin of 10.20%.The firm had revenue of $860.22 million for the quarter, compared to the consensus estimate of $837.47 million. During the same quarter in the prior year, the business earned $0.91 earnings per share. The company’s revenue was up 26.1% compared to the same quarter last year. BWX Technologies has set its FY 2026 guidance at 4.600-4.750 EPS. On average, sell-side analysts predict that BWX Technologies, Inc. will post 4.71 EPS for the current year.

BWX Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, June 5th. Stockholders of record on Tuesday, May 19th will be paid a $0.27 dividend. The ex-dividend date is Tuesday, May 19th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.5%. BWX Technologies’s dividend payout ratio is presently 28.88%.

Insider Buying and Selling

In related news, CFO Michael Thomas Fitzgerald sold 2,417 shares of the company’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $209.25, for a total value of $505,757.25. Following the completion of the transaction, the chief financial officer owned 6,884 shares of the company’s stock, valued at approximately $1,440,477. This represents a 25.99% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Rex D. Geveden sold 10,000 shares of the company’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $204.81, for a total value of $2,048,100.00. Following the completion of the transaction, the chief executive officer directly owned 202,491 shares of the company’s stock, valued at $41,472,181.71. The trade was a 4.71% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 15,744 shares of company stock worth $3,256,101 over the last ninety days. 0.60% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on BWXT shares. Bank of America boosted their price target on BWX Technologies from $230.00 to $250.00 and gave the company a “buy” rating in a research note on Wednesday, March 25th. BTIG Research boosted their price target on BWX Technologies from $225.00 to $235.00 and gave the company a “buy” rating in a research note on Thursday, February 26th. TD Cowen started coverage on BWX Technologies in a research note on Thursday, March 12th. They set a “buy” rating and a $230.00 price target on the stock. Zacks Research downgraded BWX Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, May 11th. Finally, Deutsche Bank Aktiengesellschaft upgraded BWX Technologies from a “hold” rating to a “buy” rating and boosted their price target for the company from $205.00 to $255.00 in a research note on Friday. Two analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $222.96.

BWX Technologies Company Profile

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.